Hannah Valantine's Net Worth
$333 Thousand
Who is Hannah Valantine?
Hannah Valantine does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CareDx, Inc., PACIFIC BIOSCIENCES OF CALIFORNIA, INC., and BridgeBio Pharma, Inc..
SEC CIK
Hannah Valantine's CIK is 0001855608
Past Insider Trading and Trends
2022 was Hannah Valantine's most active year for acquiring shares with 6 total transactions. Hannah Valantine's most active month to acquire stocks was the month of May. 2023 was Hannah Valantine's most active year for disposing of shares, totalling 2 transactions. Hannah Valantine's most active month to dispose stocks was the month of October. 2021 saw Hannah Valantine paying a total of $25,101.72 for 56,123 shares, this is the most they've acquired in one year. In 2023 Hannah Valantine cashed out on 5,830 shares for a total of $87,450.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CareDx, Inc. (CDNA) Snapshot price: $8.735
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +234.17% | 18.84K |
—
|
—
| 26.89K |
Jun 16
| |||
Form 4
| +9.17% | 676 |
—
|
—
| 8.05K |
Jan 6
| |||
Form 4
| +6.07% | 422 |
—
|
—
| 7.37K |
Oct 4
| |||
Form 4
| +4.91% | 325 |
—
|
—
| 6.95K |
Jul 1
| |||
Form 4
| +276.15% | 4.86K |
—
|
—
| 6.62K |
Jun 16
| |||
Form 4
| +8.04% | 131 |
—
|
—
| 1.76K |
Oct 1
| |||
Form 4
|
∞
| 1.63K |
—
|
—
| 1.63K |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) Snapshot price: $6.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BridgeBio Pharma, Inc. (BBIO) Snapshot price: $34.14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$23.10 | -$85,409.50 | 1.76K |
Feb 15
| |||
Form 5
|
∞
| 3.43K |
$12.96 | $44,475.94 | 3.43K |
Dec 28
| |||
Form 4
|
∞
| 3.43K |
$12.96 | $44,475.94 | 3.43K |
Dec 28
| |||
Form 4
|
—
|
0
|
$23.21 | -$86,050.80 | 1.76K |
Jan 16
| |||
Form 4
|
—
|
0
|
$22.28 | -$80,658.05 | 1.76K |
Scheduled
|
Dec 15
| ||
Form 4
|
—
|
0
|
$19.23 | -$62,818.25 | 1.76K |
Scheduled
|
Nov 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
∞
| 1.76K |
$14.23 | $25,101.72 | 1.76K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||